AbbVie (ABBV) Pension (2012 - 2015)

AbbVie (ABBV) posted quarterly Pension of $1.9 billion for Q4 2015, down 12.21% YoY from $2.2 billion in Q4 2014, and down 12.21% sequentially from $2.2 billion in Q4 2014.

AbbVie (ABBV) Pension (2012 - 2015) Analysis & Trends

AbbVie has disclosed Pension across 4 years of filings, most recently posting $1.9 billion for Q4 2015.

  • In Q4 2015, Pension fell 12.21% year-over-year to $1.9 billion; the TTM figure through Dec 2015 stood at $1.9 billion (down 12.21% YoY), while the FY2015 annual figure was $1.9 billion, down 12.21% from the prior year.
  • Pension retreated to $1.9 billion in Q4 2015, from $2.2 billion in the prior quarter.
  • Over the last five years, Pension for ABBV reached as high as $2.2 billion in Q4 2014 and fell as low as $979.0 million in Q4 2012.
  • The 4-year median for Pension is $1.8 billion (2013), against an average of $1.7 billion.
  • Annual changes were most pronounced in 2013 — Pension soared 66.29% — and 2015, when it slipped 12.21%.
  • A 4-year view of Pension shows it stood at $979.0 million in 2012, then surged by 66.29% to $1.6 billion in 2013, then surged by 36.36% to $2.2 billion in 2014, then dropped by 12.21% to $1.9 billion in 2015.
  • According to Business Quant data, Pension over the past three periods registered $1.9 billion, $2.2 billion, and $1.6 billion for Q4 2015, Q4 2014, and Q4 2013 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Dec 31, 2015 1.95 Bn
Dec 31, 2014 2.22 Bn
Dec 31, 2013 1.63 Bn
Dec 31, 2012 979.00 Mn